Prof. CHAN Fuk Woo, Jasper
陳福和醫生
Prof. CHAN Fuk Woo, Jasper
陳福和醫生
MBBS (HK), MD (HK), PDipID (HK), MRCP (UK), FRCP (Edin), FRCP (Glasg), FRCPath, FHKCPath, FHKAM (Pathology)
Assistant Dean (Global Engagement), Li Ka Shing Faculty of Medicine, HKU
Deputy Chairperson & Clinical Professor, Department of Microbiology, HKU
Deputy Chief-of-Service & Consultant, Department of Infectious Diseases and Microbiology, HKU-Shenzhen Hospital
Honorary Consultant, Department of Microbiology, Queen Mary Hospital
Email: jfwchan@hku.hk
HKU Scholars Hub: http://hub.hku.hk/cris/rp/rp01736
ORCID : https://orcid.org/0000-0001-6336-6657
Google Scholar: https://scholar.google.com/citations
Diagnosis, treatment, and control of emerging infectious diseases with pandemic potential and/or special relevance in Asia
Prof. Jasper Fuk-Woo Chan is currently Assistant Dean (Global Engagement), Li Ka Shing Faculty of Medicine; HKU; Deputy Chairperson and tenured Clinical Professor, Department of Microbiology, HKU; Deputy Chief-of-Service and Consultant, Department of Infectious Diseases and Microbiology, HKU-Shenzhen Hospital; and Honorary Consultant, Department of Microbiology, Queen Mary Hospital. He received his M.B.B.S. from HKU in 2005 and underwent postgraduate specialist training at the Department of Medicine and Department of Microbiology at Queen Mary Hospital from 2006-2012. He joined the Department of Microbiology at his alma mater as Clinical Assistant Professor in 2013. He was awarded the Sir Patrick Manson Gold Medal for the best M.D. thesis at HKU in 2017. He was elected as Fellow of the Infectious Diseases Society of America (FIDSA) in 2022 and as Member of the Hong Kong Young Academy of Sciences in 2024.
As a clinical microbiologist, Dr. Chan is passionate about conducting research on the diagnosis, treatment and control of emerging infectious diseases with pandemic potential and/or special relevance to Asia. He has authored/co-authored more than 330 [over 120 (co-)first/corresponding] journal publications in these areas (Scopus: h-index 84, citations >40,000), including (co-)first/corresponding-author publications in The Lancet, Science, and Nature. Dr. Chan has been consistently ranked by Clarivate as one of the world’s top 1% scholars by citations since 2015 (http://hub.hku.hk/local/top1pc/top1pc.jsp) and as a “Highly Cited Researcher” (2 fields: “Microbiology” and “Immunology”) since 2021 (https://www.hku.hk/press/press-releases/detail/25372.html). He has served as expert member or ambassador of various international organizations, including as member of the WHO ad hoc Expert Group focused on COVID-19 disease modelling (WHOCOM) and Young Ambassador of Science of the American Society for Microbiology. He has been invited to chair sessions or speak at more than 70 international and regional conferences/symposia. He is a member of the Global Advisory Board of Clinical Microbiology Reviews, an Associate Editor/Editorial Board Member of Journal of Medical Virology, Open Forum Infectious Diseases, American Journal of Transplantation, Pathogens, BMC Microbiology, and Microbes & Immunity, and has been invited to review research papers for more than 50 journals (including The Lancet, NEJM, and Nature series) and grant applications for international/national funding agencies in USA and Europe [European Research Council (ERC), Switzerland (SNSF), France (ANR), the Netherlands (NWO), Austria (FWF), Poland (NCN), and Croatia (HRZZ)]. He has received external competitive research grants as Principal Coordinator/Investigator from the Ministry of Science and Technology (National Key R&D Programme of China) and National Natural Science Foundation of China (NSFC) (General Program) (mainland China), and Research Grants Council (RGC) [Collaborative Research Fund (CRF) and General Research Fund (GRF)] and Health and Medical Research Fund (HMRF) (Hong Kong), and own a number of patents on novel diagnostics and antivirals. He has mentored 38 Ph.D. and M.Phil. students at HKU. Dr. Chan’s team reported the world’s first familial cluster of COVID-19 that confirmed person-to-person transmission of SARS-CoV-2, which resulted in major control policy changes globally (Chan et al., Lancet 2020: 1 of 34 articles highlighted in the “200 years of The Lancet timeline”). His team also established the world’s first COVID-19 Syrian hamster model, which has become one of the most commonly used COVID-19 animal models worldwide.
External (International, National, and Regional):
2024: Elected Member of the Hong Kong Young Academy of Sciences
2023: First-author research article “Chan JF et al., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395:514-523” selected as one of the 34 landmark papers in the “200 Years of The Lancet” timeline (https://www.thelancet.com/lancet-200/timeline-infographic).
2023: Highly Cited Researcher 2023 (“Microbiology”) (Clarivate)
2023: Highly Cited Researcher 2023 (“Immunology”) (Clarivate)
2023 (since 2015): Top 1% scholar (Clarivate)
2023 (since 2019): Top 2% most-cited scientist (Stanford University)
2023: The 8th VCANBIO Award for Biosciences and Medicine (VABM) (Innovation Breakthrough Award) (The University of Chinese Academy of Sciences and VCANBIO Cell & Gene Engineering Corporation Limited)
2023: 2023 Dalton Horizon Prize (Bismuth cure for COVID-19) (Royal Society of Chemistry)
2023: Gold Medal (Bismuth-based Cocktail Therapy for Coronavirus) (The 48th Geneva International Exhibition of Inventions)
2023: The IDSA Leadership Institute: Community of Leaders (IDSA)
2022: Highly Cited Researcher 2022 (“Microbiology”) (Clarivate)
2022: Highly Cited Researcher 2022 (“Immunology”) (Clarivate)
2022: Fellow of the Infectious Diseases Society of America (FIDSA)
2022: Fellow of the Royal Society of Biology (FRSB)
2022: Fellow of the Institute of Biomedical Science (FIBMS)
2021: Highly Cited Researcher 2021 (“Microbiology”) (Clarivate)
2021: Highly Cited Researcher 2021 (“Immunology”) (Clarivate)
2021: Biomedicines 2021 Young Investigator Award (Biomedicines)
2021: Pathogens 2021 Young Investigator Award (Pathogens)
2021: Emerging Microbes & Infections 2020 Best Paper Award (1st Place) (as first author) (Emerging Microbes & Infections)
2021: Prize for Best Original Research by Young Fellows (Gold Medal Winner) (Hong Kong Academy of Medicine)
2020: Lo Ying Shek Chi Wai Foundation Award for Young Investigator (Lo Ying Shek Chi Wai Foundation)
2020: Kylin Science and Technology Award Capital Excellent Science and Technology Innovation Award (Beijing Society of Science and Technology Professionals Capital, Beijing, People’s Republic of China)
2019 (since 2017): ASM Young Ambassador of Science to Hong Kong (American Society for Microbiology)
2019: State Scientific and Technological Progress Award (2nd Class Award) (the National Government of the People’s Republic of China)
2019: The Most Promising Young Researcher Award (Food and Health Bureau of the HKSAR Government)
2019: The Best Poster Award (Young Investigator Category at the 32nd International Conference on Antiviral Research by International Society for Antiviral Research)
2018: The Chinese Medical Science and Technology Award (2nd Class Award) (Chinese Medical Association)
2015: ASV Medical Virology Club Travel Award (American Society for Virology)
2011: Best Presentation Prize at the 7th Trainee Presentation Session (The Hong Kong College of Pathologists)
2010: Outstanding Team Award (Hospital Authority of Hong Kong)
Internal (The University of Hong Kong & HKUMed):
2022: HKU Research Output Prize (2021-2022) (as co-first author for the best research output in HKU LKS Faculty of Medicine in 2021)
2022: Faculty Outstanding Research Output Awards (2021-2022) (x3 as co-first author & co-author)
2022: Gold-Class 10-Year Anniversary Excellent Team Award (as Deputy Chief-of-Service) (HKU-Shenzhen Hospital)
2021: HKU Outstanding Young Researcher Award (The University of Hong Kong)
2021: HKU Research Output Prize (2020-2021) (as first author for the best research output in HKU LKS Faculty of Medicine in 2020)
2021: Faculty Outstanding Research Output Awards (2020-2021) (x2 as co-author)
2018: Sir Patrick Manson Gold Medal (LKS Faculty of Medicine, HKU)
2016: HKU Research Output Prize (as co-author for the best research output in HKU LKS Faculty of Medicine in 2015)
Research Articles:
– This article reported the world’s first evidence of person-to-person transmission of SARS-CoV-2 and was selected by The Lancet as one of the 34 papers in the ”200 Years of The Lancet” timeline (https://www.thelancet.com/lancet-200/timeline-infographic).
The Chan laboratory is recruiting MPhil & PhD students, research assistants, and Post-Doc Fellows. Interested candidates please send a cover letter detailing your research interests and CV to Dr. Jasper FW Chan (jfwchan@hku.hk).